Consumer Health Cancer / Immunology
Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EAU
Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...
March 09, 2023 | News
Hummingbird Bioscience licenses Cancer Research UK's clinical trial results to support HMBD-001 development.
The Phase 1/2a clinical trial in the United Kingdom is being sponsored and managed by CRUK's Centre for Drug Development and led by Chief Investi...
March 06, 2023 | News
C2i Genomics Expands to Japan, Announces Collab with Riken Genesis
The collaboration will expand C2i’s global reach and bring MRD cancer monitoring capabilities for solid tumors to Japan C2i Genomics...
March 03, 2023 | News
Prenetics Forms Advisory Board for Precision Oncology Strategy
Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Adviso...
March 02, 2023 | News
JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma
Primary hepatic cancer is a common malignant tumor of the digestive system worldwide, with high malignancy and hepatic prognosis. As the most common pathol...
March 01, 2023 | News
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study
To date, the study has enrolled over 18,000 individuals from a general population of 230,000 persons located in China. The test subjects were tested ...
February 23, 2023 | News
Eurofins Discovery Collaborating with Invasight on Cancer Therapies
Invasight is teaming with Eurofins Discovery's DiscoveryOne™, an integrated drug discovery platform that provides expert comprehensive support t...
February 15, 2023 | News
BeiGene Aim to Accelerate Integration of Mental Health into Quality Cancer Care
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, has released a report highlighting the challenges cancer patients and car...
February 03, 2023 | News
Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers
Based on positive clinical readouts from a Phase IIb study for isSCC and a Phase II study for BCC, Sirnaomics is formulating a communication package for th...
February 02, 2023 | News
TransCode Therapeutics Reports Positive Preclinical Results with its Immunotherapy Candidate, TTX-RIGA, in Melanoma
TransCode Therapeutics, Inc. (Nasdaq: RNAZ), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today repor...
February 01, 2023 | News
Genexine Receives Fast Track Designation from Korean Health Authority (MFDS) for its promising DNA vaccine for advanced cervical cancer
Following an evaluation of the full set of Phase 2 data from the recently completed clinical trial in advanced cervical cancer, Korea’s Health Author...
January 23, 2023 | News
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a further A$3 million secured via an Au...
January 23, 2023 | News
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
Zhongxin launched the Program aiming to navigate and solve the medication challenges faced by cancer patients. During cancer treatment process, the use of ...
January 20, 2023 | News
Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes
Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping Lunit's presentations this year will highligh...
January 19, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
